Department of General, and Endocrine Surgery, and Gastroenterologic Oncology, Poznań University of Medical Sciences, Poznań, Poland.
Faculty of Mathematics and Computer Science, Adam Mickiewicz University, Poznań, Poland.
ANZ J Surg. 2022 May;92(5):1137-1141. doi: 10.1111/ans.17656. Epub 2022 Mar 28.
There is still a search for a standard method of therapy for high anal fistulas. The aim of this trial was a comparison between a modified two stage minimally invasive procedure, consisting of loose-seton placement with the subsequent application of platelet rich plasma with mucosal advancement flap for the treatment of high transsphincteric anal fistulas of crypto-glandular origin.
The study was designed as a prospective, randomized trial including 96 patients. Curettage of fistulous tracts, and loose-seton placement was performed in those patients with active inflammation, and if the diameter of a fistulous tract exceeded 3 mm. Afterwards, the patients were randomly assigned to either the PRP group or MAF group, consisting of 49 patients, and 47 patients, respectively.
There was no significant statistical difference (p = 0.152) between both investigated groups of patients regarding closure of fistulas since it was achieved in 35 (71.43%) patients from group I, compared to 27 (57.45%) patients from group II. The diameter of fistulous tracts below 4 mm exerted a significant impact (p < 0.001) on the healing process after PRP application because fistulas with the narrow tracts were closed in 34 (87.18%) patients, whereas a wider fistula was healed in 1 (10%) patient.
The local application of PRP in high, unbranched, and with narrow tracts trans-sphincteric anal fistulas of crypto-glandular origin, following loose-seton drainage is an effective, simple, and a safe method of therapy with a low rate of morbidity.
目前仍在寻找治疗高位肛痿的标准方法。本试验旨在比较改良两阶段微创治疗方法,即松置术联合富血小板血浆(PRP)应用和黏膜推进皮瓣治疗隐源性高位经括约肌肛痿的疗效。
本研究设计为前瞻性、随机试验,纳入 96 例患者。对处于活动期且痿管直径大于 3mm 的患者进行痿管搔刮和松置术。然后,将患者随机分为 PRP 组和 MAF 组,分别有 49 例和 47 例患者。
两组患者的痿管闭合率无统计学差异(p=0.152),因为 I 组 35 例(71.43%)患者和 II 组 27 例(57.45%)患者的痿管均闭合。痿管直径小于 4mm 对 PRP 应用后的愈合过程有显著影响(p<0.001),因为狭窄痿管的愈合率为 34 例(87.18%),而较宽痿管的愈合率为 1 例(10%)。
对于隐源性高位、无分支、狭窄经括约肌肛痿,在松置术引流后局部应用 PRP 是一种有效、简单、安全的治疗方法,其发病率较低。